.INVESTIGATION EMPHASIZE.06 August 2024.
A sizable randomized controlled test with cisgender ladies highlights the difficulties of faithfulness to an everyday oral preexposure prophylaxis program and demonstrates that twice-yearly shot of lenacapavir can easily maintain reliable HIV avoidance levels over 6 months.